O'ConnellJ.B., MaggardM.A., KoC.Y.Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Nat Cancer Inst2004; 96: 1420–1425.
2.
JiS.H., ParkY.S., LeeJ., LiD.H., ParkK.W., KangJ.H.Phase II study of irinotecan, 5–fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer. Jpn J Clin Oncol2005; 35: 214–217.
3.
CassinelloJ., López-AlvarezP., Martínez-GuisadoA.Valladares M, Huidobro G, López R, et al. Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancer. Med Oncol2003; 20: 37–44.
4.
LippR.Campto®—strategies for adjuvant and neoadjuvant chemotherapy of colorectal cancer. Onkologie2000; 23: 18–22.
5.
DouillardJ.Y., CunninghamD., RothA.D., NavarroM., JamesR.D., KarasekP.Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet2000; 355: 1041–1047.
6.
BrazD.S., RibasM.M., DedivitisR.A., NishimotoI.N., BarrosA.R.Quality of life and depression in patients undergoing total and partial laryngectomy. Clinics2005; 60: 135–142.
7.
AckerstaffA.H., HilgersF.J., AaronsonN.K., BalmA.J.Communication, functional disorders and lifestyle changes after total laryngectomy. Clin Otolaryngol Allied Sci1994; 19: 295–300.
8.
BirkhaugE.J., AarstadH.J., AarstadA.K., OlofssonJ.Relation between mood, social support, and the quality of life in patients with laryngectomies. Eur Arch Otorhinolaryngol2002; 259: 197–204.
9.
WardE.C., BishopB., FrisbyJ., StevensM.Swallowing outcomes following laryngectomy and pharyngolaryngectomy. Arch Otolaryngol Head Neck Surg2002; 128: 181–186.
10.
van DamF.S., HilgersF.J., EmsbroekG., TouwFl, van AsC.J., de JongN.Deterioration of olfaction and gustation as a consequence of total laryngectomy. Laryngoscope1999; 109: 1150–1155.
11.
TatchellR.H., LermanJ.W., WattJ.Olfactory ability as a function of nasal air flow volume in laryngectomees. Am J Otolaryngol1985; 6: 426–432.
12.
CavalotA.L., GervasioC.F., NazionaleG., AlberaR., BussiM., StaffiertA.Pharyngocutaneous fistula as a complication of total laryngectomy: review of the literature and analysis of case records. Otolaryngol Head Neck Surg2000; 123: 587–592.
Redaelli de ZinisL.O., FerrariL., TomenzoliD., PremoliG., ParrinelloG., NicolaiR.Postlaryngectomy pharyngocutaneous fistula: incidence, predisposing factors, and therapy. Head Neck1999; 21: 131–138.
15.
GanlyI., PatelS., MatsuoJ., SinghB., KrauseD., BoyleJ.Postoperative complications of salvage total laryngectomy. Cancer2005; 103: 2073–2081.
16.
MarkouK.D., VlachtsisK.C., NikolaouA.C., PetridisD.G., KouloulasA.I., DaniilidisI.C.Incidence and predisposing factors of pharyngocutaneous fistula formation after total laryngectomy. Is there a relationship with tumour recurrence?Eur Arch Otorhinolaryngol2004; 261: 61–67.
17.
SchwartzS.R., YuehB., MaynardC., DaleyJ., HendersonW., KhuriS.F.Predictors of wound complications after laryngectomy: a study of over 2000 patients. Otolaryngol Head Neck Surg2004; 131: 61–68.
18.
SeikalyH., ParkP.Gastroesophageal reflux prophylaxis decreases the incidence of pharyngocutaneous fistula after total laryngectomy. Laryngoscope1995; 105: 1220–1222.
